Gastric autoimmunity in children and adolescents with type 1 diabetes: A prospective study

Hormone Research in Paediatrics

Volumn 77, Issue 2, 2012, Pages 121-126

  Kakleas, K ^a   Kostaki, M ^a   Critselis, E ^a   Karayianni, C ^a   Giannaki, M ^b   Anyfantakis, K ^b   Haramaras, I ^a   Fotinou, A ^b   Papathanasiou, A ^b   Karavanaki, K ^a  

^a P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Glutamic acid decarboxylase antibodies; Parietal cell and thyroid autoantibodies; Thyrogastric autoimmunity; Type 1 diabetes

Indexed keywords

CYANOCOBALAMIN; FERRITIN; GASTRIN; PARIETAL CELL ANTIBODY; THYROID ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CHRONIC HYPERTROPHIC GASTRITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GASTRIC AUTOIMMUNITY; GASTRIN BLOOD LEVEL; GASTROSCOPY; HELICOBACTER INFECTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; MALE; MENETRIER DISEASE; PANCREAS ISLET BETA CELL; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN BLOOD LEVEL;

ADOLESCENT; AUTOANTIBODIES; AUTOIMMUNITY; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GASTRITIS; GLUTAMATE DECARBOXYLASE; GREECE; HOSPITALS, UNIVERSITY; HUMANS; INSULIN-SECRETING CELLS; MALE; OUTPATIENT CLINICS, HOSPITAL; PARIETAL CELLS, GASTRIC; PROSPECTIVE STUDIES; THYROID GLAND;

EID: 84859922899     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000336923     Document Type: Article

References (31)

1. Borg H, Fernlund P, Sundkvist G: Protein tyrosine phosphatase-like protein IA2-antibodies plus glutamic acid decarboxylase 65 antibodies (GADA) indicates autoimmunity as frequently as islet cell antibodies assay in children with recently diagnosed diabetes mellitus. Clin Chem 1997; 43: 2358-2363. (Pubitemid 28022973)
2. Landin-Olsson M, Palmer JP, Lernmark Å, Blom L, Sundkvist G, Nyström L, Dahlquist G: Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a populationbased study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068-1073.
3. DeBlock CE, De Leeuw IH, Peleckmans PA, Callens D, Maday E, Van Gaal LF: Delayed gastric emptying and gastric autoimmunity in type 1 diabetes. Diabetes Care 2002; 25: 912-917. (Pubitemid 41094292)
4. De Block CE, De Leeuw IH, Vertommen JJ, Rooman RP, Du Caju MV, Van Campenhout CM, Weyler JJ, Winnock F, Van Autreve J, Gorus FK, Belgian Diabetes Registry: Betacell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 2001; 126: 236-241. (Pubitemid 32995137)
5. Frohlich-Reiterer EE, Huber J, Katz H, Suppan E, Obermayer-Pietsch B, Deutschmann A, et al: Do children and adolescents with type 1 diabetes mellitus have a higher frequency of parietal cell antibodies than healthy controls? J Pediatr Gastroenterol Nutr 2011; 52: 558-562.
6. De Block CE, De Leeuw IH, Rooman RP, Winnock F, Du Caju MV, Van Gaal LF: Gastric parietal cell antibodies are associated with glutamic acid decarboxylase-65 antibodies and the HLA DQA1 * 0501-DQB1 * 0301 haplotype in type 1 diabetes mellitus. Belgian Diabetes Registry. Diabet Med 2000; 17: 618-622.
7. De Block CE, De Leeuw IH, Van Gaal LF, and the Belgian Diabetes Registry: High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 diabetic patients. J Clin Endocrinol Metab 1999; 84: 4062-4067. (Pubitemid 30644195)
8. Kordonouri O, Klinghammer A, Lang EB, Gruters-Keslich A, Grabert M, Holl RW: Thyroid autoimmunity in children and adolescents with type 1 diabetes. Diabetes Care 2002; 24: 1346-1350. (Pubitemid 41071144)
9. Maugender D, Guilhem I, Karacatsanis C, Poirier JY, Leguerrier AM, Lorcy Y, Derrien C, Sonnet E, Massart C: Anti-TPO antibodies and screening of thyroid dysfunction in type 1 diabetic patients. Ann Endocrinol (Paris) 2000; 61: 524-530. (Pubitemid 32055259)
10. Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A: Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes. Diabet Med 2002; 19: 518-521. (Pubitemid 34639165)
11. Alberti KG; Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553. (Pubitemid 28319935)
12. Karavanaki K, Kakleas K, Paschali E, Kefalas N, Konstantopoulos I, Hadjiathanasiou C, Kanariou M, Karayianni C: Screening for associated autoimmunity in children and adolescents with type 1 diabetes mellitus. Horm Res 2009; 71: 201-206.
13. Kakleas K, Paschali E, Kefalas N, Fotinou A, Kanariou M, Karayianni Ch, Karavanaki K: Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Ups J Med Sci 2009; 114: 214-220.
14. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G: Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989; 2: 387-395. (Pubitemid 19171845)
15. Jaeger C, Hatziagelaki E, Petzoldt R, Bretzel RG: Comparative analysis of organ-specific autoantibodies and celiac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care 2001; 24: 27-32. (Pubitemid 32104215)
16. Jacobson DL, Gange SJ, Rose NR, Graham NM: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-243. (Pubitemid 27398022)
17. Neufeld M, Maclaren N, Blizzard R: Autoimmune polyglandular syndromes. Pediatr Ann 1980; 9: 154-163.
18. Barova H, Perusicova J, Hill M, Sterzl I, Vondra K, Masek Z: Anti-GAD-positive patients with type 1 diabetes mellitus have higher prevalence of autoimmune thyroiditis than anti-GAD negative patients with type1 and type 2 diabetes mellitus. Physiol Res 2004; 53: 279-286. (Pubitemid 38797284)
19. Talal N: Autoimmunity and the immunological network. Athritis Rheum 1978; 21: 853.
20. Decochez K, Tits J, Coolens JL, et al: High frequency of persisting or increasing isletspecific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. Diabetes Care 2000; 23: 838-844. (Pubitemid 30414203)
21. Becker KGRM, Simon JE, Bailey-Wilson B, Freidlin WE, Biddison HF, McFarland JM: Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA 1998; 95: 9979-9984.
22. Becker KG: Comparative genetics of type 1 diabetes and autoimmune disease: Common loci, common pathways? Diabetes 1999; 48: 1353-1358. (Pubitemid 29297295)
23. Silveira PA, Baxter AG, Cain WE, van Driel IR: A major linkage region on distal chromosome 4 confers susceptibility to mouse autoimmune gastritis. J Immunol 1999; 162: 5106-5111. (Pubitemid 29307111)
24. Tsai LH, Taniyama K, Tanaka C: Gammaaminobutyric acid stimulates acid secretion from the isolated guinea pig stomach. Am J Physiol 1987; 253:G601-G606.
25. Ahren B: GABA inhibits thyroid hormone secretion in the mouse. Thyroidology 1989; 1: 105-108.
26. Esteban M, Baxter AG: Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes. Clin Exp Immunol 2001; 126: 184-186. (Pubitemid 32998288)
27. De Block CEM, De Leeuw IH, Van Gaal LF: Autoimmune gastritis in type 1 diabetes: A clinically oriented review. J Clin Endocrinol Metab 2008; 93: 363-371. (Pubitemid 351240803)
28. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J: Variable hematologic presentation of autoimmune gastritis: Agerelated progression from iron deficiency to cobalamin depletion. Blood 2006; 107: 1673-1679. (Pubitemid 43242408)
29. Muhsen K, Barak M, Henig C, Alpert G, Ornoy A, Cohen D: Is the association between Helicobacter pylori infection and anemia age dependent? Helicobacter 2010; 15: 467-472.
30. Gürbüz AK, Küçükkardali Y, Yazgan Y, Ozel M, Polat T: Does eradication of Helicobacter pylori infection reduce hypergastrinema during long term therapy with proton pump inhibitors? Turk J Gastroenterol 2002; 13: 159-163. (Pubitemid 35175741)
31. Segni M, Borrelli O, Pucarelli I, Delle Fave G, Pasquino AM, Annibale B: Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid disease. J Clin Endocrinol Metab 2004; 89: 4944-4948. (Pubitemid 39391432)